An enlarged liver can affect the proper functioning of your body. If you are experiencing any symptoms of the disease, then immediate treatment is required to avoid complications. The liver is the ...

Q: Which doctor should I consult for hepatomegaly? A: A gastroenterologist should be consulted in case of hepatomegaly. A: It means that both the liver and spleen have become bigger than their normal ...

Several conditions can cause hepatomegaly, or an enlarged liver. These include liver disease or damage, cancer, and congestive heart failure. The liver is one of the most important organs in the body.

The complexity of the human body is difficult to understand, with each organ serving a unique purpose to ensure our overall well-being. Among these vital organs, the liver stands as a silent hero that ...

This page lists all known medications that could potentially lead to 'Hepatomegaly' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s) ...

The liver is the largest internal organ of the human body. Located in the upper right part of the abdomen, it is about the size of a football and weighs about 3 pounds in the average-sized adults.

Research published today in the Journal of Hepatology suggests that the protein responsible for antioxidant defenses in humans may adversely affect the liver. The research was led by postdoctoral ...

FOUR cases of hepatitis without jaundice and without hepatomegaly constitute the material of this report. Hepatitis without jaundice has been variously described as a "mild disease" 1 and "mild ...

HEPATOMEGALY has long been recognized as a frequent clinical finding in diabetes mellitus, particularly among juvenile diabetic patients. The etiology of the hepatomegaly, however, has remained a ...

Budd-Chiari syndrome. Light micrograph of a section of liver affected by Budd-Chiari syndrome. This is a rare syndrome that may occur as a result of any condition that obstructs blood flow from the ...

In this study, we report a novel ARID1B mutation identified by whole-exome sequencing in a patient with clinical features characteristic to CSS. The patient is a 16-year-old female. She is the only ...

In the ruxolitinib arm, liver volumes decreased rapidly during the first 12 weeks and continued to decrease until approximately week 48, with a mean percentage change of −10.6% at week 48 (range, ...